Review within 1 week of first prescribing, with weekly monitoring of suicidal thinking
weekly for the first month
tests per year, UK, within 1 week of first prescribing, then weekly for the first month
“see them within 1 week of first prescribing and monitor the risk of suicidal thinking and self-harm weekly for the first month”
NICE CG113 Generalised anxiety disorder and panic disorder in adults, recommendations, 2026-11-06
- Kind of source
- Clinical guideline
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- The guideline states this for people starting drug treatment for generalised anxiety disorder who are at increased risk.
Used in
Kept as evidence; no figure on the platform is computed from it yet.